Changes in plasma p-tau levels have been observed in several neurological disorders other than AD, including corticobasal syndrome,20 amyotrophic lateral sclerosis,21 and other conditions such as epilepsy,22 and traumatic encephalopathy syndrome.23 This evidence concerns the gene MAPT and corticobasal syndrome.